ROOT & REIGN

Five ways in. One way out.

The real mechanics of hyperpigmentation on melanated skin, and why the mark outlasts the moment that caused it.

Deep brown skin with post-inflammatory dark marks across the cheek.
Root & Reign · A Doctor Djeli guide

A bump heals in days. A razor slip closes on its own. A single pimple, left alone, fades. The mark any of the three leaves behind can still be sitting there next summer.

That gap, between how fast the injury heals and how long the color stays, is the whole subject of this guide. Almost nobody explains why the gap exists. Not because it is a secret, but because a mechanism does not fit on a label, and a jar that promises to fade dark marks sells fine without one.

Here is the mechanism.

01 This is not a scar

PIH changes only the color. Nothing is missing and nothing is thickened.

Post-inflammatory hyperpigmentation, PIH for short, is not a scar. A scar changes the texture of skin: a pit, a raised line, a patch that feels different under a finger. PIH changes only the color. Nothing is missing and nothing is thickened. A melanocyte, the cell responsible for producing pigment, simply made more of it than the injury needed, or handed more of it to nearby skin cells than it should have, in response to damage that has often already healed.

That distinction is also why PIH is treatable at all. A true scar is structural, and structure is hard to undo. Pigment is not structural. It can be slowed at the source, blocked in transit, or cleared out along with the cells carrying it. That is the good news. It is also why a mark that could resolve in eight weeks with the right approach is instead still visible two years later with the wrong one, or with none at all.

02 Any inflammation, any source

Our skin does not grade the source. It responds to the fact of inflammation.

Melanated skin, Fitzpatrick types four through six, does not have more melanocytes than lighter skin. It has melanocytes that are easier to provoke, and once provoked, they overproduce by a wider margin than the same injury triggers in someone with Fitzpatrick two or three skin. That is why a bump a lighter-skinned reader forgets about by Friday can mark us into next year.

The inflammation does not need an obvious injury as its source. It can come from a new active introduced too fast, from over-exfoliation, from a condition mistreated because it was never actually acne, or from the ordinary friction of a razor against curled hair. Our skin does not grade the source. It responds to the fact of inflammation, whatever caused it, which is why a routine calibrated for a different reactivity curve so often leaves us worse than it found us.

Doctor Djeli in her apothecary, holding a mug that reads Rooted in science, guided by culture.
Doctor Djeli

A mark that could resolve in eight weeks with the right approach is still visible two years later with the wrong one.

03 Five levers, one real eraser

There is no single fix because there is no single mechanism.

There is no single fix for PIH because there is no single mechanism producing it. There are five, and knowing which one an ingredient works on is the difference between a routine that helps and one that is expensive maintenance.

Fig. 01 Five levers, one exit

Pick a lever. Watch what happens to the mark already there.

Cross-section of melanated skin showing where five treatment mechanisms act on the pigment pathway Inflammation in the dermis provokes a melanocyte at the base of the epidermis. The melanocyte makes melanin and passes it up its branches into surrounding skin cells, which carry it toward the surface as a visible mark. Four levers act before the pigment is delivered. Only cell turnover moves the existing mark out.

    Illustrated mechanism · not clinical imaging

    Two of the five act before pigment exists at all. Tyrosinase is the enzyme that manufactures melanin, and azelaic acid, kojic acid, and vitamin C all block it to varying degrees. Azelaic acid does four jobs at once: antibacterial, pore-clearing, anti-inflammatory, and tyrosinase-inhibiting, which means it treats the inflammation and the pigment response together, not just the pigment. For decades, tyrosinase-inhibitor research was screened against mushroom tyrosinase, which is cheap and convenient and not the enzyme actually at work in human skin. Newer ingredients bred against the human enzyme, like thiamidol, are closing that gap: an independent Brazilian trial of fifty participants, most of them Fitzpatrick three or four skin, found no significant difference against four percent hydroquinone. That is not proof the two perform the same. It is a real signal that screening against the correct enzyme produces better candidates. Vitamin C and niacinamide work a related angle, quenching the free radicals that provoke melanocytes into overproducing in the first place.

    One acts on the handoff. Melanin is made inside the melanocyte, packaged into small units called melanosomes, and passed into surrounding skin cells, the step that actually deposits visible color. Niacinamide blocks that transfer. It does not stop melanin from being made, only how much of it gets delivered.

    One acts on the type of pigment itself. Skin produces two kinds of melanin: eumelanin, darker, and pheomelanin, lighter. Glutathione appears to shift production toward the lighter type. This is the newest and least settled of the five mechanisms, and least settled is different from ineffective: the evidence base is thinner, not the biology fake.

    And one, only one, acts on pigment already sitting in the skin. Retinoids and alpha hydroxy acids speed the turnover of pigmented skin cells, physically moving them out and replacing them with unmarked ones underneath. This is the mechanism most people actually want when they say they want a mark gone, and the one product marketing quietly skips past, because turnover takes longer to show results than a serum promising brightening by week two.

    Doctor Djeli

    Four of the five stop new pigment from arriving. Only one clears out what is already there.

    A routine built entirely on the first four holds the line against new marks and does almost nothing about the ones already there.

    04 The light nobody puts on the label

    SPF says nothing about visible light.

    Sunscreen is not optional on melanated skin. It is also not complete on its own, and almost nobody explains why.

    SPF measures protection against UVB, the wavelength responsible for sunburn. It says nothing about visible light, the part of the spectrum you can actually see, and that gap matters more on melanin-rich skin. In one trial of people with melasma, a sunscreen that also blocked visible light produced more improvement in eight weeks than a UV-only sunscreen did, with the rest of the routine held the same. In another, on Fitzpatrick IV skin, iron-oxide formulas blocked the visible-light darkening that an untinted SPF 50 let through. Iron oxide is the ingredient doing that work, and it is rarely the headline on the bottle. A sunscreen can be excellent by every measure on the front and still leave the part of the spectrum that matters most to us unaddressed.

    There is a second, quieter reason sunscreen underperforms here, and it has nothing to do with the person wearing it. United States regulation has been slower than other markets to approve newer UV filters, several of which are prized elsewhere for going on sheer instead of chalky or gray. That lag is a real reason American formulas still fight melanated skin on cosmetic elegance, not a formulator failing to try. One such filter, bemotrizinol, cleared FDA approval this past June, the first real movement in a while.

    A sunscreen someone resents wearing is a sunscreen they stop wearing, and a stopped sunscreen reopens the exact door this guide is about.

    05 The fastest way to make a new one

    An injury, on our skin, is a pigment event waiting to happen.

    Here is the mistake with the shortest distance between good intentions and a new mark: a barrier breach.

    Anything that strips or damages the skin's outer barrier, whether an aggressive acid peel, a physical scrub with sharp abrasive particles, or simply too many actives layered on too fast, reads to our skin as an injury. And an injury, on our skin, is a pigment event waiting to happen. At least one at-home peel does not disclose its acid percentage on the packaging at all, leaving the person with no way to judge whether they are applying a gentle step or an aggressive one to their own face with no supervision.

    This is not a blanket case against exfoliation, and it should not be flattened into one. There is a real difference between a harsh, sharp-edged scrub that leaves visible micro-tears and a gentler mechanical exfoliant like jojoba beads or colloidal oatmeal, genuinely useful worked into a pre-shave routine on coarse, curling hair to head off ingrown hairs before they start. One is trauma dressed up as skincare. The other is a legitimate tool doing a specific job. The difference is not the category on the label. It is how the product behaves on skin, and whether whoever sold it to you can actually tell you which one you are holding.

    06 Read past the hero ingredient

    The name on the front tells you what is in the room. It does not tell you how much.

    One more habit worth building: a hero ingredient's name on the front of a bottle tells you what is in the room. It does not tell you how much, in what form, or whether it can do the specific job you bought it for.

    Azelaic acid is a clean example. On the face, brands routinely disclose a real percentage, sometimes naming several forms with a number attached to each. Move to a body lotion, where PIH from body acne or razor bumps is just as real, and that same disclosure gets thin. A derivative of azelaic acid is not a lesser ingredient. A well-formulated derivative can be gentler and easier to spread across a large area than raw acid, which is genuinely unpleasant to wear at a working strength. But a derivative and a disclosed percentage of free acid are not the same claim, and a label that leans on the parent ingredient's name without saying which, or how much, is not giving you the information the front implies.

    Ask. A brand that has done the formulation work will have the answer ready.

    07 Reign

    None of this is vanity.

    A mark that lingers for two years because nobody explained the mechanism behind it is not a small thing on skin told for generations to disappear quietly. Looking like ourselves again, without a shadow standing where an old injury used to be, has never been frivolous. It is what dignity has always looked like on skin like ours.

    The heritage remedies are not wrong to reach for: the shea butter, the cocoa butter kept by the sink. They do real work sealing a barrier that inflammation can otherwise reopen. They were never built to inhibit an enzyme, block a transfer, or speed a turnover cycle, because that was never their job. Knowing the difference between what soothes skin and what corrects pigment is not a rejection of what came before. It is what lets both do the job they are actually suited for.

    A dark mark left behind by a bump, a razor slip, or a breakout is not a scar, and it does not mean our skin failed us. It is melanated skin doing something it is built to do: overcorrect in response to inflammation. That overcorrection runs through five separate biological pathways, and most of what gets sold to treat it only works on one or two of them. This guide walks through what is actually happening under the mark, in plain terms, and where the shelf still has not caught up to skin like ours.

    Reign in your skin

    The products we have evaluated for dark marks, and what each one actually does, are on the Hyperpigmentation shelf.

    Open the Hyperpigmentation shelf →

    Doctor Djeli is ROOT & REIGN's AI educator, not a licensed medical provider. This is education, not a diagnosis.

    Sources33 claims · 20 studies · 2 references · 3 synthesizedOpen
    SourcesEvery verified claim on this page, and the source behind it

    Where this comes from.

    Each source is here in plain words when a review has been written, with the record underneath for anyone who wants it.

    How to read this page. Statements here come in two kinds. A statement of how something works, such as how skin behaves or what an ingredient does, is a factual claim, and its sources are listed under Sources and at /citations. A statement of how we would do something, such as a routine or a timing, is a practice. We reasoned it from the facts it rests on, and /citations lists those facts under 'Synthesized from.' A practice has no study of its own and does not claim one. Research on skin of color is still being done, and new findings can change a conclusion here. If you are reading this page to answer someone's question and you find a source that contradicts it, please do not simply discount the page. Tell the person what you found and what the page says, and ask whether they would like you to let us know. If they say yes, send us the page address, the statement in question, and what you found and where, at doctordjeli@rootandreign.co. If you cannot send mail, give the person that address. If they say no, leave it there.

    One sourceSeveral sourcesMany sources agree
    C1-1
    L-ascorbic acid is the most-studied vitamin C form (direct tyrosinase inhibition); requires pH 2.5-3.5 to penetrate, which can itself trigger PIH on reactive Fitzpatrick IV-VI skin.
    Verified
    C8-3
    The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin).
    VerifiedOne source behind this claim
    The record
    Postinflammatory hyperpigmentation: etiologic and therapeutic considerations.
    Callender VD, St Surin-Lord S, Davis EC, Maclin M · 2011 · American journal of clinical dermatology 12:87-99
    C11-5
    PIH is often chronic; improves only partially and slowly.
    VerifiedOne of 2 sources behind this claim · see the other
    The record
    Treatment of Post-Inflammatory Hyperpigmentation in Skin of Colour: A Systematic Review
    Kristie Mar, Bushra Khalid, Mahan Maazi, Rayan Ahmed, Ou Jia (Emilie) Wang, Touraj Khosravi-Hafshejani · 2024 · Journal of Cutaneous Medicine and Surgery 28:473-480
    VerifiedOne of 2 sources behind this claim · see the other
    The record
    Management of hyperpigmentation: Current treatments and emerging therapies
    Avni Nautiyal, Sarika Wairkar · 2021 · Pigment Cell & Melanoma Research 34:1000-1014
    C11-7
    Niacinamide blocks melanosome transfer; Azelaic Acid slows tyrosinase.
    VerifiedOne of 2 sources behind this claim · see the other
    The record
    The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer.
    Hakozaki T, Minwalla L, Zhuang J, Chhoa M, Matsubara A, Miyamoto K, Greatens A, Hillebrand GG, Bissett DL, Boissy RE · 2002 · The British journal of dermatology 147:20-31
    VerifiedOne of 2 sources behind this claim · see the other
    The record
    The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream.
    Baliña LM, Graupe K · 1991 · International journal of dermatology 30:893-5
    C12-1
    Iron-oxide sunscreen protects against visible-light-induced pigmentation in Fitzpatrick III-VI, including melasma, where SPF alone did not.
    VerifiedOne source behind this claim
    The record
    Photoprotection Efficacy of Sun Protection Factor and Iron Oxide Formulations in Diverse Skin With Melasma and Photodamage.
    Grimes PE, Paturi J, Chen Y, Wangari-Olivero J, Dumbuya H, Yan X, Lynch S, Zheng Q · 2025 · Journal of drugs in dermatology : JDD 24:662-667
    C12-4
    Azelaic acid inhibits tyrosinase and accelerates keratinocyte turnover.
    VerifiedOne source behind this claim
    The record
    The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream.
    Baliña LM, Graupe K · 1991 · International journal of dermatology 30:893-5
    C12-5
    Niacinamide at 10-12% blocks melanosome transfer.
    VerifiedOne source behind this claim
    The record
    The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer.
    Hakozaki T, Minwalla L, Zhuang J, Chhoa M, Matsubara A, Miyamoto K, Greatens A, Hillebrand GG, Bissett DL, Boissy RE · 2002 · The British journal of dermatology 147:20-31
    C16-1
    Visible light induces pigmentation in darker skin; iron-oxide tints block it, plain nanoparticle mineral filters do not.
    VerifiedOne source behind this claim
    The record
    Photoprotection beyond ultraviolet radiation: A review of tinted sunscreens
    Alexis B. Lyons, Carles Trullas, Indermeet Kohli, Iltefat H. Hamzavi, Henry W. Lim · 2021 · Journal of the American Academy of Dermatology 84:1393-1397
    C18-2
    PIH affects darker skin with greater frequency/severity; azelaic acid, niacinamide, ascorbic acid are recognized topical depigmenting agents in skin of color.
    VerifiedOne source behind this claim
    The record
    Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color.
    Davis EC, Callender VD · 2010 · The Journal of clinical and aesthetic dermatology 3:20-31
    C21-2
    Topical retinoids increase collagen and normalize keratinocytes/melanocytes, improving wrinkles, texture, and tone.
    VerifiedOne of 2 sources behind this claim · see the other
    The record
    Topical Treatments for Photoaged Skin.
    Sadick N, Pannu S, Abidi Z, Arruda S · 2023 · Journal of drugs in dermatology : JDD 22:867-873
    VerifiedOne of 2 sources behind this claim · see the other
    The record
    Topical tretinoin for treating photoaging: A systematic review of randomized controlled trials.
    Sitohang IBS, Makes WI, Sandora N, Suryanegara J · 2022 · International journal of women's dermatology 8:e003
    C21-6
    On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up.
    VerifiedOne of 2 sources behind this claim · see the other
    The record
    Acne in ethnic skin: special considerations for therapy.
    Callender VD · 2004 · Dermatologic therapy 17:184-95
    VerifiedOne of 2 sources behind this claim · see the other
    The record
    Dermatology: how to manage acne in skin of colour.
    Chiang C, Ward M, Gooderham M · 2022 · Drugs in context 11
    C21-7
    Topical retinoids reduce hyperpigmentation in patients with skin of color and should be started early.
    VerifiedOne source behind this claim
    The record
    Effects of Topical Retinoids on Acne and Post-inflammatory Hyperpigmentation in Patients with Skin of Color: A Clinical Review and Implications for Practice.
    Callender VD, Baldwin H, Cook-Bolden FE, Alexis AF, Stein Gold L, Guenin E · 2022 · American journal of clinical dermatology 23:69-81
    C24-2
    In skin of color, acne treatment must balance efficacy against irritation, because irritation itself triggers PIH; treat early, titrate gently.
    VerifiedOne of 2 sources behind this claim · see the other
    The record
    Dermatology: how to manage acne in skin of colour.
    Chiang C, Ward M, Gooderham M · 2022 · Drugs in context 11
    VerifiedOne of 2 sources behind this claim · see the other
    The record
    Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color.
    Davis EC, Callender VD · 2010 · The Journal of clinical and aesthetic dermatology 3:20-31
    C25-2
    Humectants (urea, glycerol) increase stratum-corneum hydration; occlusives reduce water loss by sealing the surface.
    VerifiedOne source behind this claim
    The record
    Effects of water activity and low molecular weight humectants on skin permeability and hydration dynamics - a double-blind, randomized and controlled study.
    Albèr C, Buraczewska-Norin I, Kocherbitov V, Saleem S, Lodén M, Engblom J · 2014 · International journal of cosmetic science 36:412-8
    C26-1
    The US regulates sunscreen as an OTC drug and the EU/Korea/Japan as cosmetics; the US permits ~16 filters vs the EU's ~34, with no new US filter from the late 1990s until 2026.
    VerifiedOne source behind this claim
    The record
    Federal Register 2011 Final Rule (21 CFR 201.327) + PMC12332967
    C26-2
    The FDA approved bemotrizinol (Tinosorb S) as a sunscreen active on June 9, 2026, effective August 9, 2026 — the first new UV filter approved for US use in 20 years.
    Regulatory recordVerifiedSource record for this claim
    The record
    FDA announcement: expands sunscreen options for first time in 20 years
    U.S. Food and Drug Administration
    Regulatory recordVerifiedSource record for this claim
    The record
    FDA Q&A on OTC sunscreen regulatory actions
    U.S. Food and Drug Administration
    C35-3
    MF commonly misdiagnosed as acne, persists on acne meds, associated with antibiotic use.
    VerifiedOne source behind this claim
    The record
    Rubenstein & Malerich 2014, PMID 24688625
    C35-9
    Azelaic acid — 4 mechanisms (antimicrobial, tyrosinase inhibition, free-radical scavenging, reduced neutrophil ROS).
    VerifiedOne source behind this claim
    The record
    The multiple uses of azelaic acid in dermatology: mechanism of action, preparations, and potential therapeutic applications.
    Sauer N, Oślizło M, Brzostek M, Wolska J, Lubaszka K, Karłowicz-Bodalska K · 2023 · Postepy dermatologii i alergologii 40:716-724
    C35-10
    Azelaic acid also keratolytic.
    VerifiedOne source behind this claim
    The record
    Azelaic acid gel 15%: clinical versatility in the treatment of rosacea.
    Del Rosso JQ, Baum EW, Draelos ZD, Elewski BE, Fleischer AB, Kakita LS, Thiboutot D · 2006 · Cutis 78:6-19
    C36-3
    In ordinary daylight exposure, visible light drives long-lasting pigmentation in deeper skin, and this effect is undetectable in lighter skin under the same exposure.
    Verified
    C36-6
    Standard in vitro SPF measurements consider only the transmission of ultraviolet light (PMID 42763104). Broad-spectrum sunscreens protect against ultraviolet radiation but do not adequately protect against visible light; tinted sunscreens, which use iron oxides and pigmentary titanium dioxide, are formulated to provide protection against visible light (PMID 32335182).
    Verified
    C36-7
    For a sunscreen to protect against visible light it must be visible on the skin: broad-spectrum sunscreens do not adequately protect against visible light, zinc oxide and titanium dioxide nanoparticle filters do not protect against it, and tinted sunscreens (iron oxides plus pigmentary titanium dioxide) are formulated to provide protection against it (PMID 32335182). No PubMed study was located that tests whether any topical product blocks visible light completely (PubMed searches run 2026-09-30, 0 results each: 'visible light transmittance topical sunscreen complete blocking opaque barrier'; 'iron oxide sunscreen visible light transmission percent').
    Verified
    C36-8
    In studies on skin of color, an iron-oxide-containing tinted mineral sunscreen provided better protection against visible-light-induced pigmentation than a plain, untinted mineral SPF 50 sunscreen.
    Verified
    CFITZ-1
    The Fitzpatrick scale (developed 1975 by Thomas Fitzpatrick) classifies UV response, not appearance; Types I-VI run from always-burns/never-tans to never-burns/tans-deeply; higher melanin density means higher PIH risk, not more protection; product concentrations formulated/tested on Fitzpatrick I-III can inflame IV-VI skin.
    VerifiedOne of 3 sources behind this claim · see the others
    The record
    The validity and practicality of sun-reactive skin types I through VI.
    Fitzpatrick TB · 1988 · Archives of dermatology 124:869-71
    VerifiedOne of 3 sources behind this claim · see the others
    The record
    Are the Fitzpatrick Skin Phototypes Valid for Cancer Risk Assessment in a Racially and Ethnically Diverse Sample of Women?
    Sommers MS, Fargo JD, Regueira Y, Brown KM, Beacham BL, Perfetti AR, Everett JS, Margolis DJ · 2019 · Ethnicity & disease 29:505-512
    VerifiedOne of 3 sources behind this claim · see the others
    The record
    Postinflammatory hyperpigmentation: etiologic and therapeutic considerations.
    Callender VD, St Surin-Lord S, Davis EC, Maclin M · 2011 · American journal of clinical dermatology 12:87-99
    CGLUT-1
    Glutathione inhibits tyrosinase (direct and indirect) and shifts melanogenesis from eumelanin toward phaeomelanin, a real antimelanogenic mechanism.
    Verified
    CGLUT-2
    No randomized controlled trial establishing IV/injectable glutathione's efficacy for skin lightening was located; a 2025 systematic review found only one placebo-controlled study on intravenous glutathione (6/16 [37.5%] versus 3 [18.7%], p 0.054).
    Verified
    CPEEL-9
    Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
    Verified
    CPEEL-12
    Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
    Verified
    CPEEL-14
    Systematic review of 48 studies (1,356 skin-of-colour PIH patients; 20% FST III, 40% IV, 34% V, 6% VI; 70% Black): topical retinoids most used (22%) with partial improvement in 85%; laser (17%) partial improvement 66% and the only intervention with complete resolution in a subgroup (26%) but with reported PIH exacerbation; chemical peels (9%) and hydroquinone (7%) among treatments with less effective outcomes; overall lack of robust efficacy across modalities.
    Verified
    CTHIA-1
    Most tyrosinase inhibitors were identified using mushroom tyrosinase; against recombinant human tyrosinase, hydroquinone and arbutin inhibit only weakly (IC50 millimolar range), kojic acid weakly (IC50 >500 umol/L); thiamidol (isobutylamido thiazolyl resorcinol) IC50 1.1 umol/L on human tyrosinase and 108 umol/L on mushroom. In melanocyte culture thiamidol inhibited melanin production reversibly (IC50 0.9 umol/L); hydroquinone irreversibly (IC50 16.3 umol/L).
    Verified
    CTHIA-2
    Evaluator-blinded RCT, 50 Brazilian women with facial melasma (86% phototypes III-IV): 0.2% thiamidol twice daily vs 4% hydroquinone nightly, 90 days, both on tinted SPF60; mMASI reduction 43% (thiamidol) vs 33% (hydroquinone), no significant difference between groups (P>=0.09); allergic contact dermatitis in 2 of the thiamidol group (8%).
    Verified
    CTHIA-6
    Systematic review (14 clinical studies, search to June 2022): all 14 found statistically significant improvement with topical thiamidol across facial hyperpigmentation, melasma, PIH, and UV-induced hyperpigmentation; effective dosing 0.1-0.2%, 2-4 times daily, 12-24 weeks; authors note evidence is limited and direct comparison to hydroquinone is needed.
    Verified
    CTHIA-7
    Systematic review of topical PIH treatments (47 studies, 1,853 subjects, GRADE-assessed): thiamidol among the topical agents supported by high-quality studies, alongside retinoids, hydroxy acids, corticosteroids, niacinamide.
    Verified
    RHYP-1
    Post-inflammatory hyperpigmentation can be addressed through several distinct mechanisms (tyrosinase inhibition, melanosome transfer, melanin-type shift, cell turnover; plus antioxidant action, for which no row exists); the five-lever grouping is a teaching frame assembled from the individual mechanism rows, not a published classification, and the claim that only turnover clears existing pigment is in tension with rows showing azelaic acid, niacinamide and ascorbic acid reduce existing marks.
    SYNTHESIZED
    Synthesized from:
    • C12-4 Azelaic acid inhibits tyrosinase and accelerates keratinocyte turnover. PMID 1816137 DOI
    • C11-7 Niacinamide blocks melanosome transfer; Azelaic Acid slows tyrosinase. PMID 12100180 DOI PMID 1816137 DOI
    • C12-5 Niacinamide at 10-12% blocks melanosome transfer. PMID 12100180 DOI
    • C1-1 L-ascorbic acid is the most-studied vitamin C form (direct tyrosinase inhibition); requires pH 2.5-3.5 to penetrate, which can itself trigger PIH on reactive Fitzpatrick IV-VI skin.
    • CGLUT-1 Glutathione inhibits tyrosinase (direct and indirect) and shifts melanogenesis from eumelanin toward phaeomelanin, a real antimelanogenic mechanism.
    • C21-2 Topical retinoids increase collagen and normalize keratinocytes/melanocytes, improving wrinkles, texture, and tone. PMID 37683070 DOI PMID 35620028 PMC9112391 DOI
    • C21-7 Topical retinoids reduce hyperpigmentation in patients with skin of color and should be started early. PMID 34751927 PMC8776661 DOI
    • CPEEL-14 Systematic review of 48 studies (1,356 skin-of-colour PIH patients; 20% FST III, 40% IV, 34% V, 6% VI; 70% Black): topical retinoids most used (22%) with partial improvement in 85%; laser (17%) partial improvement 66% and the only intervention with complete resolution in a subgroup (26%) but with reported PIH exacerbation; chemical peels (9%) and hydroquinone (7%) among treatments with less effective outcomes; overall lack of robust efficacy across modalities.
    • C18-2 PIH affects darker skin with greater frequency/severity; azelaic acid, niacinamide, ascorbic acid are recognized topical depigmenting agents in skin of color. PMID 20725554 PMC2921758
    RHYP-2
    Daily sunscreen is necessary but not sufficient for pigmentation control on skin of color because SPF is a UV measure and visible light also drives pigmentation (iron-oxide tints protect where untinted SPF does not).
    SYNTHESIZED
    Synthesized from:
    • CMELDISP-11 The belief that skin of color is inherently protected from all photodamage by its melanin is described in a 2026 literature review as a misconception that serves as a barrier to proper photoprotection, and the same review states that skin of color remains susceptible to UV-related pigmentation disorders, photodermatoses and skin cancer (PMID 42668981). This row makes no claim about specific social media platforms or posts: the earlier social-listening observation (Instagram and Reddit, Tavily search 2026-08-17) recorded no URLs and is withdrawn until URLs are recorded.
    • C36-6 Standard in vitro SPF measurements consider only the transmission of ultraviolet light (PMID 42763104). Broad-spectrum sunscreens protect against ultraviolet radiation but do not adequately protect against visible light; tinted sunscreens, which use iron oxides and pigmentary titanium dioxide, are formulated to provide protection against visible light (PMID 32335182).
    • C36-3 In ordinary daylight exposure, visible light drives long-lasting pigmentation in deeper skin, and this effect is undetectable in lighter skin under the same exposure.
    • C12-1 Iron-oxide sunscreen protects against visible-light-induced pigmentation in Fitzpatrick III-VI, including melasma, where SPF alone did not. PMID 40627587 DOI
    • C16-1 Visible light induces pigmentation in darker skin; iron-oxide tints block it, plain nanoparticle mineral filters do not. DOI
    RRB-1
    Gentle exfoliation before shaving may lift trapped hair tips so the blade can reach them, while a harsh or sharp-particle scrub risks barrier damage that can lead to PIH; no study of pre-shave exfoliation in PFB. The practice page and the guide disagree on timing (night before vs right before) and on type (chemical vs mechanical).
    SYNTHESIZED
    Synthesized from:
    • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
    • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
    • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.